Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Endece
AddedFeb 15, 2024
UpdatedJun 18, 2026
Endece

Endece

Pre-Seed

US-based Endece, LLC manufactures and processes pharmaceutical drugs for human and veterinary use.

HQ
Mequon, WI, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Founded in the United States, Endece, LLC is dedicated to the discovery and development of pharmaceutical drugs for both human and veterinary use. The company's core mission is to create treatments that halt disease progression, restore function, and improve quality of life. Endece's flagship product, NDC-1308, is a novel therapeutic designed to treat neurodegenerative diseases such as Multiple Sclerosis by inducing remyelination and inhibiting demyelination, setting it apart from other MS drugs on the market.

Notable figures affiliated with Endece include Dr. James Yarger, Ph.D., who serves as President. The company has garnered attention for its innovative approach to treating neurodegenerative diseases, particularly through the development of NDC-1308. This drug's unique mechanism-of-action has positioned Endece as a significant player in the pharmaceutical industry, contributing to advancements in medical treatments for debilitating conditions.

Endece - Similar Companies

Endogenx logo

Endogenx

Endevica Bio logo

Endevica Bio

endevicabio.com

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Caden Biosciences logo

Caden Biosciences

Cadenza Bio logo

Cadenza Bio

cadenza.bio

Endlyz Therapeutics logo

Endlyz Therapeutics

Zocere logo

Zocere

zocere.com

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Endosphere logo

Endosphere

Neurodon logo

Neurodon

neurodon.net

Adenios logo

Adenios

Cerevance logo

Cerevance

cerevance.com

Ensysce Biosciences logo

Ensysce Biosciences

ensysce.com

Genendeavor logo

Genendeavor

genendeavor.com

GlobeStar Therapeutics logo

GlobeStar Therapeutics

Endece - Quick Facts

Who are Endece's competitors?

Companies similar to Endece include Endogenx, Endevica Bio, NeuroGenetic Pharmaceuticals and Caden Biosciences.

When was Endece founded?

Endece was founded in 2006.

Where is Endece's headquarters located?

Endece's headquarters is located in Mequon, WI, US.

When was Endece's last funding round?

Endece's most recent funding round was for $1.2M (USD) in July 2011.

How much has Endece raised to-date?

As of Jul 20, 2011, Endece has raised a total of $7.4M (USD).

How many employees does Endece have?

Endece has 5 employees as of Feb 4, 2024.

Endece - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drugs
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 8690Other human health activities
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified